1-50 of 89
Keywords: neurodegeneration
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem Soc Trans (2024) 52 (4): 1809–1825.
Published: 03 July 2024
... 4.0 (CC BY) . Open access for this article was enabled by the participation of University of Sheffield in an all-inclusive Read & Publish agreement with Portland Press and the Biochemical Society under a transformative agreement with JISC. ALS condensate neurodegeneration nuclear body...
Articles
Biochem Soc Trans (2024) 52 (3): 961–972.
Published: 30 May 2024
... 5 2024 © 2024 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2024 amyotrophic lateral sclerosis biomolecular condensates intrinsically disordered proteins Matrin-3 neurodegeneration RNA-binding proteins Matrin-3 (MATR3...
Articles
Biochem Soc Trans (2024) 52 (3): 1035–1044.
Published: 25 April 2024
... neurodegeneration remains highly debated. Here, we discuss known links between embryonic neurogenesis and neurodegenerative disorders (including common signaling pathways), potential compensatory mechanisms that could delay presentation of neurodegenerative disorders, and the types of model systems that could...
Articles
Articles
Biochem Soc Trans (2024) 52 (2): 539–551.
Published: 25 March 2024
... and the effects of disease-associated variants remains a vital step in the understanding of neurodegeneration and the development of therapeutics. Disease modelling using patient induced pluripotent stem cells (iPSCs) has enabled the generation of key cell-types associated with disease whilst maintaining...
Articles
Biochem Soc Trans (2023) 51 (2): 571–577.
Published: 09 March 2023
... neurodegenerative diseases, which implicate either enhanced or reduced ER–mitochondria contacts in neurodegeneration. Taken together, the discussed studies highlight the need for further research into the role of triple organelle contacts, as well as into the exact mechanisms of increased and decreased ER...
Articles
Articles
Biochem Soc Trans (2023) 51 (1): 147–159.
Published: 11 January 2023
... membrane, compromising its integrity, and affecting the function of receptors. These facts indicate that the interaction between Aβ oligomers and cell membranes may be one of the central molecular level factors responsible for the onset of neurodegeneration. The present review provides a structural...
Articles
Biochem Soc Trans (2022) 50 (5): 1457–1469.
Published: 05 October 2022
... published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . autophagy neurodegeneration organelles protein quality control ubiquitin Valosin-containing protein (VCP, also p97, or Cdc48p in yeast...
Articles
Biochem Soc Trans (2022) 50 (5): 1489–1503.
Published: 16 September 2022
... in which neurodegeneration mainly affects upper and/or lower motor neurons (MNs). Although the involvement of specific MNs, symptoms, age of onset, and progression differ in MNDs, the main pathogenic mechanism common to most MNDs is represented by proteostasis alteration and proteotoxicity...
Articles
In Collection
Cell death and survival
Biochem Soc Trans (2022) 50 (2): 799–811.
Published: 28 March 2022
... LUBAC inhibitors neurodegeneration Substrates can be modified by different ubiquitin moieties at diverse sites, and the modified substrate is decoded by distinct proteins with ubiquitin recognition domains. At least ∼10 000 ubiquitination sites have been identified in human cells [ 8...
Articles
Biochem Soc Trans (2022) 50 (2): 759–771.
Published: 21 March 2022
... of disease-associated proteins ( Figure 2 ). ageing neurodegeneration protein aggregation proteostasis Table 1. Disease-associated proteins and their aggregation and sequestration patterns Protein Name Disease Aggregate Structure Aggregate Subcellular Localization PQC...
Articles
Biochem Soc Trans (2022) 50 (1): 119–134.
Published: 23 December 2021
...-liquid phase separation state caused by these repeat RNAs and repeat polypeptides, as well as potential therapeutic approaches against repeat expansion diseases. liquid-liquid phase separation neurodegeneration RAN translation repeat expansion diseases The human genome contains many simple...
Articles
Biochem Soc Trans (2021) 49 (6): 2777–2786.
Published: 23 November 2021
... and the Biochemical Society under a transformative agreement with JISC. alpha-synuclein electron microcopy neurodegeneration tau protein Many neurodegenerative diseases are characterized by the presence in the brain of abnormal fibrous deposits. Two of the most common conditions are Alzheimer's...
Articles
Biochem Soc Trans (2020) 48 (4): 1795–1806.
Published: 14 August 2020
... group member [ 61 ]. Binding of the correct HSP70 chaperone to mutant SOD1 is, therefore, an important indicator of the fate, and therefore the toxicity, of a mutant SOD1 molecule. amyotrophic lateral sclerosis molecular chaperones neurodegeneration Parkinson's disease pharmacological...
Articles
Biochem Soc Trans (2019) 47 (6): 1651–1660.
Published: 17 December 2019
... such as in brain tumors, following injury and in neurodegenerative disorders and is highly associated with glial reactivity as well as scar formation. As a key modulator of the immune response during neurodegeneration in the CNS, tenascin-C is highlighted in this mini-review. Correspondence: Andreas Faissner...
Articles
Biochem Soc Trans (2019) 47 (3): 827–838.
Published: 13 May 2019
... alpha-synuclein LRRK2 neurodegeneration Parkinson's disease tau Parkinson's disease (PD) is a complex neurodegenerative disorder clinically known for typical motor features that include muscular rigidity, resting tremor, bradykinesia, and postural instability. In addition, a variety of non...
Articles
Biochem Soc Trans (2019) 47 (2): 663–670.
Published: 05 March 2019
... LRRK2-associated phosphorylation events predict disease risk. biomarker exosome LRRK2 neurodegeneration Parkinson disease Genome-wide association studies have identified variants in or nearby the leucine-rich repeat kinase 2 (LRRK2) gene in Parkinson's disease (PD) [ 1 ]. In unbiased...
Articles
Biochem Soc Trans (2018) 46 (5): 1063–1072.
Published: 21 September 2018
..., including cancer and neurodegeneration, are associated with the loss of the Golgi ribbon and the appearance of a dispersed fragmented Golgi. Here, we review the emerging theme of the Golgi as a cell sensor and highlight the relationship between the morphological status of the Golgi in vertebrate cells...
Articles
Biochem Soc Trans (2018) 46 (4): 829–842.
Published: 09 July 2018
... in disease. Recent advances in understanding mitochondrially controlled cell death pathways and elucidating the mitochondrial permeability pore bioarchitecture are beginning to present new avenues to target neurodegeneration. Novel mitochondrial roles of deubiquitinating enzymes are coming to light...
Articles
Articles
Biochem Soc Trans (2017) 45 (4): 1025–1033.
Published: 21 July 2017
... by which misfolded proteins affect mitochondrial function and ROS production and how mitochondrial dysfunction and protein aggregation could be related to progressive neuronal death in different forms of neurodegeneration. For long time, the role of misfolded proteins in mitochondrial function...
Articles
Biochem Soc Trans (2017) 45 (2): 381–387.
Published: 13 April 2017
... secretory trafficking and cell migration via interaction with p115 . Mol. Biol. Cell 26 , 2263 – 2278 doi: 10.1091/mbc.E15-03-0178 26 Alvarez-Miranda , E.A. , Sinnl , M. and Farhan , H. ( 2015 ) Alteration of Golgi structure by stress: a link to neurodegeneration? Front...
Articles
Biochem Soc Trans (2017) 45 (1): 101–112.
Published: 15 February 2017
... contributes to aging. Conversely, studies using genetically tractable model organisms argue that adaptation to environmental stress or resistance to proteotoxicity can extend lifespan [ 7 ]. neurodegeneration protein phosphatases therapeutics translation factors unfolded protein response ©...
Articles
Biochem Soc Trans (2017) 45 (1): 155–162.
Published: 15 February 2017
...) 2017 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . autophagy leucine-rich repeat kinase neurodegeneration Parkinson's disease Leucine-rich repeat...
Articles
Biochem Soc Trans (2017) 45 (1): 163–172.
Published: 15 February 2017
... are known to form aggregates in PD brains harboring LRRK2 mutations, to neurodegeneration in LRRK2 rodent models. We aim to provide a clear and unbiased review of some of the key mechanisms that are important for LRRK2-dependent neurodegeneration in PD. Correspondence: Darren J. Moore ( darren.moore...
Articles
Biochem Soc Trans (2016) 44 (6): 1625–1634.
Published: 02 December 2016
... tandem domain mutations ( Table 1 ). Taken together, these observations are consistent with GTP-bound LRRK2 being pathogenic and raise the possibility of targeting LRRK2 GTP-binding for PD treatment. Intriguingly, a LRRK2 GTP-binding inhibitor has been reported to reduce neurodegeneration in mouse models...
Articles
Biochem Soc Trans (2016) 44 (2): 659–661.
Published: 11 April 2016
....2014.08.020 25203713 6 Schapira A.H. Complex I: inhibitors, inhibition and neurodegeneration Exp. Neurol. 2010 224 331 335 10.1016/j.expneurol.2010.03.028 20362572 7 Cannon J.R. Tapias V. Na H.M. Honick A.S. Drolet R.E. Greenamyre J.T. A highly...
Articles
Biochem Soc Trans (2016) 44 (1): 177–184.
Published: 09 February 2016
... affinity [ 31 ]. WIPI-2 has not been tested thus far due to instability. Despite the similarities between Atg18 and WIPI-1,2,3 and 4, it is not clear whether WIPI proteins regulate PI(3,5) P 2 levels in mammalian cells. Fab1 Fig 4 lysosome neurodegeneration PIKfyve Vac14 Phosphorylated...
Articles
Biochem Soc Trans (2015) 43 (4): 559–565.
Published: 03 August 2015
... or therapeutic agents. Recent researches have reported that TSPO ligands might be valuable in the treatment of brain diseases. This review focuses on currently available TSPO ligands, as useful tools for the treatment of neurodegeneration, neuro-inflammation and neurotrauma. 1 To whom correspondence...
Articles
Biochem Soc Trans (2015) 43 (4): 621–626.
Published: 03 August 2015
... kinase beta (IKKβ) Kelch-like ECH-associated protein 1 (Keap1) nuclear factor (erythroid-derived 2)-like 2 (Nrf2) nuclear factor-κB (NF-κB) neurodegeneration Figure 2 Common interactions between p65 and Nrf2 Data obtained from BioGRID were filtered to remove those identified only by co...
Articles
Biochem Soc Trans (2015) 43 (4): 627–631.
Published: 03 August 2015
... in the tissue microenvironment. However, both aging and neurodegeneration involve an up-regulation of processes, such as oxidative stress, inflammation, somatic mutations, and reduction in growth factors in neural tissues, which threaten the robust functioning of NSCs. Nevertheless, recent evidence also...
Articles
Biochem Soc Trans (2015) 43 (3): 333–337.
Published: 01 June 2015
... extended to treatment of chronic neurodegenerative diseases in two mouse models. Concurrently studies have demonstrated the importance of the regulation of protein synthesis, translation, to the cooling response, which is also emerging as a targetable process in neurodegeneration. Through these studies...
Articles
Biochem Soc Trans (2015) 43 (2): 292–296.
Published: 07 April 2015
... neurodegeneration in PD or not. Here, we bear in mind such a key question and move from a brief insight into the basis of MT functions in neurons to the evidence that MT dysfunction occurs in experimental parkinsonism and, finally, to the critical discussion on the interplay between parkin and MT system in cellular...
Articles
Biochem Soc Trans (2014) 42 (5): 1291–1301.
Published: 18 September 2014
... the role of glia in neurodegeneration in an attempt to identify novel targets that could be used to develop much-needed strategies for the containment and cure of neurodegenerative disorders. We discuss this in the context of glial roles in the homoeostasis and defence of the brain. We consider...
Articles
Biochem Soc Trans (2014) 42 (4): 1069–1074.
Published: 11 August 2014
...Paola Venco; Sabrina Dusi; Lorella Valletta; Valeria Tiranti NBIA (neurodegeneration with brain iron accumulation) comprises a heterogeneous group of neurodegenerative diseases having as a common denominator, iron overload in specific brain areas, mainly basal ganglia and globus pallidus...
Articles
Biochem Soc Trans (2014) 42 (4): 1075–1079.
Published: 11 August 2014
...-review summarized the diverse functionality of CoA, apart from its most classically known metabolic role. It is now necessary for the future to understand the complex consequences of impaired CoA de novo biosynthesis in diseases including neurodegeneration. Resolving such a challenge can be aided both...
Articles
Biochem Soc Trans (2014) 42 (4): 1025–1032.
Published: 11 August 2014
[email protected] ). anti-metabolite coenzyme A (CoA) neurodegeneration pantothenate protein acetylation vanin Anyone who took a first year undergraduate biochemistry course will (hopefully!) recall that coenzyme A (CoA) is a ubiquitous coenzyme which functions as an acyl group carrier...
Articles
Biochem Soc Trans (2014) 42 (2): 593–599.
Published: 20 March 2014
... the Lifespan: Translational Neuroscience from Molecule to Man: An Independent Meeting held at University College Cork, Ireland, 12–13 September 2013. Organized and Edited by Eoin Fleming (University College Cork, Ireland). memory neurodegeneration oxidative stress synaptic plasticity...
Articles
Biochem Soc Trans (2013) 41 (6): 1577–1582.
Published: 20 November 2013
... The Authors Journal compilation © 2013 Biochemical Society 2013 brain cannabinoid system interleukin-1β neural stem cell fate neurodegeneration neurogenesis neuroprotection Although much has been learnt in recent years about the causes of degeneration within the brain, in terms...
Articles
Biochem Soc Trans (2013) 41 (6): 1541–1545.
Published: 20 November 2013
... astrocytes have on neuronal health under both normal and pathological contexts, and suggest that the classically neurocentric view of neurodegeneration should be expanded to include an assessment of astrocytic health and function, as neuronal demise would undoubtedly be accelerated by astrocytic decline...
Articles
Biochem Soc Trans (2013) 41 (6): 1483–1488.
Published: 20 November 2013
...Jaime L. Schneider; Ana Maria Cuervo The importance of cellular quality-control systems in the maintenance of neuronal homoeostasis and in the defence against neurodegeneration is well recognized. Chaperones and proteolytic systems, the main components of these cellular surveillance mechanisms...
Articles
Biochem Soc Trans (2013) 41 (1): 241–244.
Published: 29 January 2013
... (to R.S.)]. exosome microvesicle neurodegeneration neuron synaptic plasticity The function of the brain relies on the capacity of billions of synapses to transmit patterns of electrical information through neuronal circuits. Reinforcement of circuits underlying associations and memory...
Articles
Biochem Soc Trans (2013) 41 (1): 101–105.
Published: 29 January 2013
... Journal compilation © 2013 Biochemical Society 2013 brain aging c-Jun N-terminal kinase (JNK) energy metabolism insulin/insulin-like growth factor-1 signalling mitochondrion neurodegeneration A decrease in energy metabolism, leading to a hypometabolic state, is associated with brain...
Articles
Biochem Soc Trans (2012) 40 (5): 1123–1128.
Published: 19 September 2012
... genetics of Parkinson's disease leucine-rich repeat kinase 2 (LRRK2) neurodegeneration Parkinson's disease treatment Wnt signalling PD (Parkinson's disease) is the second most prevalent neurodegenerative disease worldwide. Individuals with PD present with typical motor symptoms...
Articles
Biochem Soc Trans (2012) 40 (4): 687–692.
Published: 20 July 2012
...Tara M. Caffrey; Richard Wade-Martins The microtubule-associated protein tau ( MAPT or tau) is of great interest in the field of neurodegeneration as there is a well-established genetic link between the MAPT gene locus and tauopathies, a diverse group of neurodegenerative dementias and movement...
Articles
Biochem Soc Trans (2012) 40 (4): 656–660.
Published: 20 July 2012
... will require the identification of common mechanisms of tau neurotoxicity, and pathways that can be modulated to protect against neurodegeneration. Model organisms, such as Caenorhabditis elegans , provide methods for identifying novel genes and pathways that are involved in tau pathology and may be exploited...
Articles
Biochem Soc Trans (2012) 40 (4): 739–745.
Published: 20 July 2012
... and significant time and cost savings between Drosophila and mammalian models makes them an attractive proposition for genetic modifier screening. Drosophila genetic modifier genetic screening Huntington's disease neurodegeneration HD (Huntington's disease) is a fatal neurodegenerative...
Articles
Articles
Biochem Soc Trans (2011) 39 (4): 924–932.
Published: 20 July 2011
... detrimental effects. 1 email [email protected] 27 2 2011 © The Authors Journal compilation © 2011 Biochemical Society 2011 Alzheimer's disease (AD) animal model apolipoprotein E (apoE) cognitive impairment neurodegeneration ApoE, a 299-amino-acid glycoprotein...